Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meixiang Biotechnology, primarily operating as Shanghai Meixiang Biotechnology Co., Ltd., is a life sciences company specializing in the development and supply of high-quality research reagents and diagnostic materials. The company focuses on the production of recombinant proteins, monoclonal and polyclonal antibodies, and ELISA kits used in various research and clinical applications. Beyond product supply, Meixiang Biotechnology provides contract research services (CRO) including protein expression, antibody development, and assay optimization. Their portfolio supports a wide range of therapeutic areas, including oncology, immunology, and infectious diseases, by providing essential tools for drug discovery and diagnostic development. The company is headquartered in Shanghai and serves both domestic and international academic and industrial clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meixiang Biotechnology.